172 related articles for article (PubMed ID: 27477101)
1. Efficient production of nanoparticle-loaded orodispersible films by process integration in a stirred media mill.
Steiner D; Finke JH; Kwade A
Int J Pharm; 2016 Sep; 511(2):804-13. PubMed ID: 27477101
[TBL] [Abstract][Full Text] [Related]
2. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
Steiner D; Finke JH; Kwade A
Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
[TBL] [Abstract][Full Text] [Related]
3. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
Speer I; Preis M; Breitkreutz J
Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
[TBL] [Abstract][Full Text] [Related]
4. Instant ODFs - Development of an intermediate, nanoparticle-based product platform for individualized medication.
Steiner D; Finke JH; Kwade A
Eur J Pharm Biopharm; 2018 May; 126():149-158. PubMed ID: 28414191
[TBL] [Abstract][Full Text] [Related]
5. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on disintegration methods for oral film preparations.
Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on novel test systems to determine disintegration time of orodispersible films.
Preis M; Gronkowsky D; Grytzan D; Breitkreutz J
J Pharm Pharmacol; 2014 Aug; 66(8):1102-11. PubMed ID: 24673551
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
[TBL] [Abstract][Full Text] [Related]
9. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
Thabet Y; Lunter D; Breitkreutz J
Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
[TBL] [Abstract][Full Text] [Related]
10. SOFTs - Structured orodispersible film templates.
Steiner D; Finke JH; Kwade A
Eur J Pharm Biopharm; 2019 Apr; 137():209-217. PubMed ID: 30836181
[TBL] [Abstract][Full Text] [Related]
11. Anti-solvent Precipitation Method Coupled Electrospinning Process to Produce Poorly Water-Soluble Drug-Loaded Orodispersible Films.
Song Q; Guo X; Sun Y; Yang M
AAPS PharmSciTech; 2019 Aug; 20(7):273. PubMed ID: 31385126
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles facilitating the dissolution of poorly soluble drugs in orodispersible films.
Ṣen Karaman D; Patrignani G; Rosqvist E; Smått JH; Orłowska A; Mustafa R; Preis M; Rosenholm JM
Eur J Pharm Sci; 2018 Sep; 122():152-159. PubMed ID: 29966736
[TBL] [Abstract][Full Text] [Related]
13. Orodispersible Films for Compounding Pharmacies.
Ferreira AO; Brandão MAF; Raposo FJ; Polonini HC; Raposo NRB
Int J Pharm Compd; 2017; 21(6):454-461. PubMed ID: 29220334
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Oral Cavity Model for Screening the Disintegration Behavior of Orodispersible Films: A Bespoke Design.
Redfearn A; Scarpa M; Orlu M; Hanson B
J Pharm Sci; 2019 May; 108(5):1831-1836. PubMed ID: 30639737
[TBL] [Abstract][Full Text] [Related]
15. Drug-printing by flexographic printing technology--a new manufacturing process for orodispersible films.
Janssen EM; Schliephacke R; Breitenbach A; Breitkreutz J
Int J Pharm; 2013 Jan; 441(1-2):818-25. PubMed ID: 23266759
[TBL] [Abstract][Full Text] [Related]
16. Critical Material Attributes of Strip Films Loaded With Poorly Water-Soluble Drug Nanoparticles: II. Impact of Polymer Molecular Weight.
Krull SM; Ammirata J; Bawa S; Li M; Bilgili E; Davé RN
J Pharm Sci; 2017 Feb; 106(2):619-628. PubMed ID: 27871727
[TBL] [Abstract][Full Text] [Related]
17. Embedding of Poorly Water-Soluble Drugs in Orodispersible Films-Comparison of Five Formulation Strategies.
Steiner D; Tidau M; Finke JH
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678646
[TBL] [Abstract][Full Text] [Related]
18. Empagliflozin containing chitosan-alginate nanoparticles in orodispersible film: preparation, characterization, pharmacokinetic evaluation and its
Sinha S; Sonali ; Garg V; Thapa S; Singh S; Chauhan M; Dutt R; Singh RP
Drug Dev Ind Pharm; 2022 Jul; 48(7):279-291. PubMed ID: 35913103
[TBL] [Abstract][Full Text] [Related]
19. Micronized Zaleplon Delivery via Orodispersible Film and Orodispersible Tablets.
Manda P; Popescu C; Juluri A; Janga K; Kakulamarri PR; Narishetty S; Narasimha Murthy S; Repka MA
AAPS PharmSciTech; 2018 Apr; 19(3):1358-1366. PubMed ID: 29352403
[TBL] [Abstract][Full Text] [Related]
20. Orodispersible Films: A Systematic Patent Review.
Gijare C; Deshpande A
Recent Pat Drug Deliv Formul; 2018; 12(2):110-120. PubMed ID: 29745346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
